As Insulin Producers Shift Focus, rBIO Emerges to Combat Shortages With major insulin manufacturers pivoting towards profit-driven drugs, rBIO is committed to producing affordable biosimilar insulin to ensure patient access amid potential shortages.

As Insulin Producers Shift Focus, rBIO Emerges to Combat Shortages #USA #Houston #rBIO #biosimilar_insulin #insulin_shortage